Companies

Should Amgen split as Loeb suggests?

Activist investor Dan Loeb wants the biotechnology company Amgen to think about splitting into two. Lex's Oliver Ralph and Robert Armstrong discuss why splits are advocated and whether it would work in Amgen's case.